BioTechReport-Tipp Apontis Pharma startet durch
Apontis Pharma, ein führendes Pharmaunternehmen für Single Pills im deutschen Markt, hat mit einem starken ersten Halbjahr seine Top-Position am Markt ausgebaut. 12.08.2021
Source: deraktionaer.de
Page 9 - Single Pills News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Single Pills. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Single Pills Today - Breaking & Trending Today
Investegate |APONTIS PHARMA AG Announcements | APONTIS PHARMA AG: APONTIS PHARMA marks further success in the roll-out of Single Pill therapy
DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance APONTIS PHARMA marks further success in the roll-out of Single Pill therapy 12.07.2021 / 07:30 APONTIS PHARMA marks further success in the roll-out of Single Pill therapy Monheim am Rhein, 12 July 2021. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the German market, continues to achieve success in the roll-out of its own product portfolio. The therapeutic effectiveness of Single Pills was verified in the study "Effect of Single pill combinations on Treatment Real-w...
Source: investegate.co.uk
APONTIS PHARMA marks further success in the roll-out of Single Pill therapy
APONTIS PHARMA marks further success in the roll-out of Single Pill therapy DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance 12.07.2021 / 07:30 APONTIS PHARMA marks further success in the roll-out of Single Pill therapy Monheim am Rhein, 12 July 2021. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the German market, continues to achieve success in the roll-out of its own product portfolio. The therapeutic effectiveness of Single Pills was verified in the study "Effect of Single pill combinations on Treatment Real...
Source: dgap.de
DGAP-News: APONTIS PHARMA AG: APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie
DGAP-News: APONTIS PHARMA AG: APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie 12.07.2021 / 07:30 APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie Monheim am Rhein, 12. Juli 2021 . Die APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), ein führendes Pharmaunternehmen für Single Pills im deutschen Markt, macht weitere Fortschritte bei der Verbreitung des eigenen Produktportfolios. Den Therapieerfolg der Single Pills belegt die 2019 durchgefü...
Source: finanznachrichten.de
Investegate |APONTIS PHARMA AG Announcements | APONTIS PHARMA AG: APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
DGAP-News: APONTIS PHARMA AG / Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share 06.05.2021 / 20:09 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share Total...
Source: investegate.co.uk